Ownership as of March 31, 2020. Twenty largest shareholders.
NameSeries A sharesSeries B sharesShare capital %Voting rights %
ANNWALL & ROTHSCHILD INVESTMENTS AB377 736410 4787.0228.63
FJÄRDE AP FONDEN01 112 9199.917.61
ÖHMAN BANK S.A.01 106 4529.867.57
SWEDBANK ROBUR NY TEKNIK BTI0579 1725.163.96
TREDJE AP-FONDEN0507 0644.523.47
AMF AKTIEFOND SMÅBOLAG0501 5854.473.43
UNIONEN0447 1963.983.06
HANDELSBANKEN SVENSKA, SMABOLAGSFOND0385 5003.212.46
CBNY-NORGES BANK0313 0002.792.14
DANGOOR, DAVID0283 5012.521.94
ANDRA AP-FONDEN0263 5002.351.8
SWEDBANK ROBUR MICROCAP0250 0002.231.71
ÅLANDSBANKEN I ÄGARES STÄLLE0239 3572.131.64
BANQUE PICTET & CIE SA, W8IMY0235 3802.11.61
SEB AB, LUXEMBOURG BRANCH, W8IMY0231 0162.061.58
RBC INVESTOR SERVICES BANK S.A0222 7081.981.52
FÖRSÄKRINGSAKTIEBOLAGET, AVANZA PENSION0201 2581.791.38
HANDELSBANKEN MICROCAP SVERIGE0170 2201.521.16
NORDNET PENSIONSFÖRSÄKRING AB0160 8891.431.1
Sub-total377 7367 621 19571.0377.77
Other shareholders03 227 25328.9722.23
Total377 73610 848 448100100
Source: Euroclear Sweden AB
The total registered share capital of Infant Bacterial Therapeutics AB consists of 377,736 class A shares with 10 votes per share and 10,848,448 class B shares with one vote per share, in total 11,226,184 shares.